Skip to main content
. 2019 Apr 18;8(5):30. doi: 10.1038/s41389-019-0139-x

Fig. 1. TRIM56 relates to poor endocrine treatment outcome and correlates with ER alpha and PR protein levels in human breast cancer samples.

Fig. 1

A–C TRIM56 mRNA level correlates with poor endocrine treatment outcome in breast cancer patients. Each panel is derived from independent clinical cohorts. These clinical data are acquired from KMPLOT database (http://kmplot.com/analysis/). D Examples of positive/negative TRIM56, ERα, PR and HER2 staining in breast tumor samples were shown by ×100 magnification. The statistical data of each protein marker are shown in Table 1